Frontier IP Group Stock

Frontier IP Group Equity

The The Equity of Frontier IP Group (FIPP.L) as of Aug 13, 2026 is 42.00 M GBP. In the previous year, The Equity was 44.77 M GBP — a change of -6.19% (lower).

Equity

42.00 MGBP

YoY

-6.19%

Last updated:

In 2026, Frontier IP Group's equity was 42.00 M GBP, a -6.19% increase from the 44.77 M GBP equity in the previous year.

Access this data via the Eulerpool API

Frontier IP Group Stock analysis

What does Frontier IP Group do? The Frontier IP Group PLC is a British company specializing in technology investment and listed on the London Stock Exchange. The company was founded in 2000 and is headquartered in London. Frontier IP invests in promising technology companies and supports them in the development of their products. The business model of Frontier IP is based on investing in promising companies to further develop their technology and business areas. The company has extensive experience in technology development and marketing and works closely with its portfolio companies. Currently, Frontier IP is investing in numerous companies in various sectors such as biotechnology, artificial intelligence, environmental technology, and agricultural technology. The investments range from start-up companies to established companies already present in the market. Each company in which Frontier IP is involved has unique technologies and innovations in the field of research and development, which have a significant impact on their respective markets. The products and services offered by Frontier IP and its portfolio companies include various biotechnological products and procedures, including antibodies, vaccines, and cell therapies. Frontier IP also invests in companies that develop advanced sensor technologies, robotics, and AI systems that can contribute to the automation of various industries. One example is The Vaccine Group. The Vaccine Group was founded in 2003 as a spin-off from the University of Plymouth and is a leading developer of novel human vaccines. The focus is on developing vaccines against infectious diseases classified as special challenges by the World Health Organization (WHO). Another example is Exscientia. Exscientia specializes in applied AI technology to accelerate drug discovery and development. The company has already achieved several groundbreaking successes and collaborates with leading pharmaceutical companies to develop innovative formulations with shorter development times. Frontier IP has also invested in Cambridge Raman Imaging Limited, which has developed an innovative method for high-speed imaging of cells and biological samples. This technology can be used in medical diagnostics or in the development of new drugs. Overall, Frontier IP Group is a significant company in the technology and investment industry. The company specializes in investing in promising technology companies and has extensive expertise in technology development and marketing. Through its investments, Frontier IP has already developed innovative products and services that have a significant impact on various industries and markets and will continue to play an important role in the future. Frontier IP Group is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Frontier IP Group's Equity

Frontier IP Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Frontier IP Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Frontier IP Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Frontier IP Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Frontier IP Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Frontier IP Group stock

The Equity of Frontier IP Group is 42.00 M GBP in 2026.

The Equity of Frontier IP Group changed from 44.77 M GBP to 42.00 M GBP, representing a -6.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Frontier IP Group since 2006 – with annual values, charts, and detailed analysis.

The Equity's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Frontier IP Group historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Frontier IP Group

All Key Metrics — Frontier IP Group